Cargando…

Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination

Dysfunctional mitochondria are linked to several neurodegenerative diseases. Metabolic defects, a symptom which can result from dysfunctional mitochondria, are also present in spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease, the most frequent, dominantly inherited neurodeg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harmuth, Tina, Weber, Jonasz J., Zimmer, Anna J., Sowa, Anna S., Schmidt, Jana, Fitzgerald, Julia C., Schöls, Ludger, Riess, Olaf, Hübener-Schmid, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180688/ https://www.ncbi.nlm.nih.gov/pubmed/35682609 http://dx.doi.org/10.3390/ijms23115933

Ejemplares similares

Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013)

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2
por: Bux, Jessica, et al.
Publicado: (2023)

Neurodegenerative phosphoprotein signaling landscape in models of SCA3
por: Sowa, Anna S., et al.
Publicado: (2021)

Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions
por: Sowa, Anna S., et al.
Publicado: (2022)

From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2014)

Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3
por: Harmuth, Tina, et al.
Publicado: (2018)

Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2022)

Stage-dependent biomarker changes in spinocerebellar ataxia type 3
por: Faber, Jennifer, et al.
Publicado: (2023)

Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
por: Garcia‐Moreno, Hector, et al.
Publicado: (2022)

Correspondence on “Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment” by Roux et al.
por: Park, Joohyun, et al.
Publicado: (2021)

Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
por: Menzies, Fiona M., et al.
Publicado: (2010)

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
por: Wilke, Carlo, et al.
Publicado: (2020)

KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP
por: Abeditashi, Mahkameh, et al.
Publicado: (2022)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Neuroradiological Findings in the Spinocerebellar Ataxias
por: Meira, Alex Tiburtino, et al.
Publicado: (2019)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021)

Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias
por: Kishimoto, Yoshiyuki, et al.
Publicado: (2022)

Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2
por: Dabla, Surekha, et al.
Publicado: (2022)

Genetic and molecular aspects of spinocerebellar ataxias
por: Honti, Viktor, et al.
Publicado: (2005)

Decreasing fall risk in spinocerebellar ataxia
por: Santos de Oliveira, Laura Alice, et al.
Publicado: (2015)

Spinocerebellar ataxia-10 with paranoid schizophrenia
por: Trikamji, Bhavesh, et al.
Publicado: (2015)

Spinocerebellar Ataxia Type 31 with Blepharospasm
por: Itaya, Sakiko, et al.
Publicado: (2018)

Diagnosis of Spinocerebellar Ataxia in the West Indies
por: Yearwood, Ashley K., et al.
Publicado: (2018)

Nonmotor symptoms in spinocerebellar ataxias (SCAs)
por: Moro, Adriana, et al.
Publicado: (2019)

Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias
por: Robinson, Katherine J., et al.
Publicado: (2020)

Functionality and disease severity in spinocerebellar ataxias
por: da CRUZ, Geanison Castro, et al.
Publicado: (2022)

Temporal Dynamics of the Scale for the Assessment and Rating of Ataxia in Spinocerebellar Ataxias
por: Moulaire, Paul, et al.
Publicado: (2022)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
por: Stallworth, Jeannette Y., et al.
Publicado: (2022)

Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset
por: Jacobi, Heike, et al.
Publicado: (2023)

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6
por: Tezenas du Montcel, Sophie, et al.
Publicado: (2014)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
por: Niewiadomska-Cimicka, Anna, et al.
Publicado: (2020)

Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6
por: Jacobi, Heike, et al.
Publicado: (2022)

Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17
por: Nethisinghe, Suran, et al.
Publicado: (2018)

Protein-protein interaction networks in the spinocerebellar ataxias
por: Rubinsztein, David C
Publicado: (2006)

Axonal inclusions in spinocerebellar ataxia type 3
por: Seidel, Kay, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f8g3a9o2t5pk547uj19kqjh858